Protein aggregation--pathways and influencing factors
- PMID: 20188160
- DOI: 10.1016/j.ijpharm.2010.02.025
Protein aggregation--pathways and influencing factors
Abstract
Proteins generally will tend to aggregate under a variety of environmental conditions in comparison with small drug molecules. The extent of aggregation is dependent on many factors that can be broadly classified as intrinsic (primary, secondary, tertiary or quaternary structure) or extrinsic (environment in which protein is present, processing conditions, etc). These protein aggregates may exhibit less desirable characteristics like reduced or no biological activity, potential for immunogenicity or other side effects. Protein aggregation remains one of the major challenges in the development and commercialization of biotechnology products. This article is intended to review and discuss the latest understandings in protein aggregation pathways and the possible extrinsic factors that affect or control the protein aggregation process.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Protein aggregation and its inhibition in biopharmaceutics.Int J Pharm. 2005 Jan 31;289(1-2):1-30. doi: 10.1016/j.ijpharm.2004.11.014. Epub 2005 Jan 6. Int J Pharm. 2005. PMID: 15652195 Review.
-
Predicting solution aggregation rates for therapeutic proteins: approaches and challenges.Int J Pharm. 2011 Oct 14;418(2):318-33. doi: 10.1016/j.ijpharm.2011.03.064. Epub 2011 Apr 8. Int J Pharm. 2011. PMID: 21497188
-
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Food Chem Toxicol. 2008. PMID: 18328408 Review.
-
Formulation and manufacturability of biologics.Curr Opin Biotechnol. 2009 Dec;20(6):708-14. doi: 10.1016/j.copbio.2009.10.006. Epub 2009 Oct 31. Curr Opin Biotechnol. 2009. PMID: 19880308 Review.
-
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates.Eur J Pharm Biopharm. 2006 Feb;62(2):121-30. doi: 10.1016/j.ejpb.2005.08.008. Epub 2005 Oct 10. Eur J Pharm Biopharm. 2006. PMID: 16221544 Review.
Cited by
-
Influence of the production system on the surface properties of influenza A virus particles.Eng Life Sci. 2017 Jul 18;17(10):1071-1077. doi: 10.1002/elsc.201700058. eCollection 2017 Oct. Eng Life Sci. 2017. PMID: 32624734 Free PMC article.
-
Comparison of the pH- and thermally-induced fluctuations of a therapeutic antibody Fab fragment by molecular dynamics simulation.Comput Struct Biotechnol J. 2021 May 4;19:2726-2741. doi: 10.1016/j.csbj.2021.05.005. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34093988 Free PMC article.
-
Response surface methodology for optimizing the bovine serum albumin fibrillation.Protein J. 2012 Aug;31(6):457-65. doi: 10.1007/s10930-012-9422-9. Protein J. 2012. PMID: 22648691
-
In-Vial Detection of Protein Denaturation Using Intrinsic Fluorescence Anisotropy.Anal Chem. 2023 Feb 7;95(5):2774-2782. doi: 10.1021/acs.analchem.2c03912. Epub 2023 Jan 25. Anal Chem. 2023. PMID: 36696963 Free PMC article.
-
Optimization of Water Lentil (Duckweed) Leaf Protein Purification: Identification, Structure, and Foaming Properties.Foods. 2023 Sep 14;12(18):3424. doi: 10.3390/foods12183424. Foods. 2023. PMID: 37761132 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources